CY1107326T1 - Μικροσωματιδια με απορροφητικες επιφανειες, μεθοδοι κατασκευης αυτων και χρησεις αυτων - Google Patents

Μικροσωματιδια με απορροφητικες επιφανειες, μεθοδοι κατασκευης αυτων και χρησεις αυτων

Info

Publication number
CY1107326T1
CY1107326T1 CY20061100736T CY061100736T CY1107326T1 CY 1107326 T1 CY1107326 T1 CY 1107326T1 CY 20061100736 T CY20061100736 T CY 20061100736T CY 061100736 T CY061100736 T CY 061100736T CY 1107326 T1 CY1107326 T1 CY 1107326T1
Authority
CY
Cyprus
Prior art keywords
microparticles
methods
smokes
constructing
absorbent surfaces
Prior art date
Application number
CY20061100736T
Other languages
Greek (el)
English (en)
Inventor
Hagen Derek O'
Manmohan Singh
Gary S Ott
John Barackman
Jina Kazzaz
Original Assignee
Novartis Vaccines And Diagnostics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines And Diagnostics, Inc. filed Critical Novartis Vaccines And Diagnostics, Inc.
Publication of CY1107326T1 publication Critical patent/CY1107326T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Steroid Compounds (AREA)
CY20061100736T 1998-07-29 2006-06-05 Μικροσωματιδια με απορροφητικες επιφανειες, μεθοδοι κατασκευης αυτων και χρησεις αυτων CY1107326T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12453398A 1998-07-29 1998-07-29
US28585599A 1999-04-02 1999-04-02
EP99937664A EP1100468B1 (en) 1998-07-29 1999-07-29 Microparticles with adsorbent surfaces, methods of making same, and uses thereof

Publications (1)

Publication Number Publication Date
CY1107326T1 true CY1107326T1 (el) 2012-11-21

Family

ID=26822700

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061100736T CY1107326T1 (el) 1998-07-29 2006-06-05 Μικροσωματιδια με απορροφητικες επιφανειες, μεθοδοι κατασκευης αυτων και χρησεις αυτων

Country Status (12)

Country Link
EP (1) EP1100468B1 (enExample)
JP (2) JP4601168B2 (enExample)
AT (1) ATE321535T1 (enExample)
AU (1) AU763975B2 (enExample)
CA (1) CA2338646C (enExample)
CY (1) CY1107326T1 (enExample)
DE (1) DE69930642T2 (enExample)
DK (1) DK1100468T3 (enExample)
ES (1) ES2260923T3 (enExample)
NZ (1) NZ509853A (enExample)
PT (1) PT1100468E (enExample)
WO (1) WO2000006123A1 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1156781B1 (en) 1999-02-26 2005-06-08 Chiron Corporation Microemulsions with adsorbed macromolecules and microparticles
US7713739B1 (en) 2000-11-17 2010-05-11 Novartis Vaccines And Diagnostics, Inc. Microparticle-based transfection and activation of dendritic cells
AU2001281921A1 (en) * 2000-06-29 2002-01-08 Bernina Biosystems Gmbh Bdellosomes
MXPA03002643A (es) 2000-09-28 2003-06-19 Chiron Corp Composiciones de microparticulas y metodos para producirlas.
EP1438323A4 (en) * 2001-10-03 2007-08-01 Novartis Vaccines & Diagnostic ADJUVOUS MENINGOCOCCUS COMPOSITIONS
US7838015B2 (en) * 2001-10-03 2010-11-23 Novartis Vaccines And Diagnostics, Inc. Adjuvanted meningococcus compositions
AR045702A1 (es) * 2001-10-03 2005-11-09 Chiron Corp Composiciones de adyuvantes.
EP2572707A3 (en) 2002-02-20 2013-11-06 Novartis Vaccines and Diagnostics, Inc. Microparticles with adsorbed polypeptide-containing molecules
CA2501476A1 (en) * 2002-10-07 2004-04-22 Chiron Corporation Hiv vaccine formulations
EP2263687B1 (en) 2002-12-27 2015-03-25 Novartis Vaccines and Diagnostics, Inc. Immunogenic compositions containing phospholipid
US7731967B2 (en) 2003-04-30 2010-06-08 Novartis Vaccines And Diagnostics, Inc. Compositions for inducing immune responses
JP5557415B2 (ja) 2003-06-02 2014-07-23 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 吸着させたトキソイドおよび多糖類含有抗原を含む微粒子に基づく免疫原性組成物
FR2859909B1 (fr) 2003-09-22 2007-09-07 Biomerieux Sa Procede de preparation de microparticules bioresorbables, microparticules obtenues et utilisation
US7899527B2 (en) * 2004-05-13 2011-03-01 Palo Alto Investors Treatment of conditions through modulation of the autonomic nervous system during at least one predetermined menstrual cycle phase
CN101072585A (zh) 2004-11-01 2007-11-14 诺华疫苗和诊断公司 产生免疫应答的组合方法
EP1812056B1 (en) 2004-11-15 2013-08-07 Novartis Vaccines and Diagnostics, Inc. Immunogenic compositions containing anthrax antigen, biodegradable polymer microparticles, and polynucleotide-containing immunological adjuvant
CA2631714C (en) 2005-12-02 2014-09-16 Novartis Ag Nanoparticles for use in immunogenic compositions
US8431160B2 (en) 2006-02-24 2013-04-30 Novartis Ag Microparticles containing biodegradable polymer and cationic polysaccharide for use in immunogenic compositions
EP3067048B1 (en) 2007-12-07 2018-02-14 GlaxoSmithKline Biologicals SA Compositions for inducing immune responses
EP2282771B1 (en) 2008-04-28 2014-06-25 Novartis AG Method for producing nanoparticles
BRPI1012036A2 (pt) 2009-05-27 2017-10-10 Selecta Biosciences Inc nanocarreadores que possuem componentes com diferentes taxas de liberação
JP5867952B2 (ja) 2009-06-10 2016-02-24 ノバルティス アーゲー ベンゾナフチリジン含有ワクチン
EP2525815B1 (en) * 2010-01-24 2015-02-25 Novartis AG Irradiated biodegradable polymer microparticles
CA2798739A1 (en) 2010-05-26 2011-12-01 Selecta Biosciences, Inc. Nanocarrier compositions with uncoupled adjuvant
KR20130121699A (ko) 2010-05-28 2013-11-06 테트리스 온라인, 인코포레이티드 상호작용 혼성 비동기 컴퓨터 게임 기반구조
US9192661B2 (en) 2010-07-06 2015-11-24 Novartis Ag Delivery of self-replicating RNA using biodegradable polymer particles
EA201390660A1 (ru) 2010-11-05 2013-11-29 Селекта Байосайенсиз, Инк. Модифицированные никотиновые соединения и связанные способы
MX350258B (es) 2011-07-06 2017-08-31 Novartis Ag Emulsiones cationicas de aceite en agua.
JP6059220B2 (ja) 2011-07-06 2017-01-18 ノバルティス アーゲー 核酸を含む水中油型エマルジョン
KR20140050698A (ko) 2011-07-29 2014-04-29 셀렉타 바이오사이언시즈, 인크. 체액성 및 세포독성 t 림프구(ctl) 면역 반응을 발생시키는 합성 나노운반체
EP2968510B1 (en) 2013-03-14 2019-10-09 President and Fellows of Harvard College Nanoparticle-based compositions
CA3246538A1 (en) 2022-03-30 2023-10-05 Evonik Operations Gmbh Formulations composed of cationic lipids and poly(lactic-co-glycolic acid) for the administration of polynucleotides into cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE252894T1 (de) * 1995-01-05 2003-11-15 Univ Michigan Oberflächen-modifizierte nanopartikel und verfahren für ihre herstellung und verwendung
GB9514285D0 (en) * 1995-07-13 1995-09-13 Univ Nottingham Polymeric lamellar substrate particles for drug delivery
US5759583A (en) * 1995-08-30 1998-06-02 Syntex (U.S.A.) Inc. Sustained release poly (lactic/glycolic) matrices
ATE235890T1 (de) * 1997-01-30 2003-04-15 Chiron Corp Verwendung von mikropartikeln mit adsorbiertem antigen zur stimulierung der immunabwehr

Also Published As

Publication number Publication date
CA2338646C (en) 2008-10-07
JP4601168B2 (ja) 2010-12-22
ATE321535T1 (de) 2006-04-15
ES2260923T3 (es) 2006-11-01
EP1100468A1 (en) 2001-05-23
AU5245299A (en) 2000-02-21
DK1100468T3 (da) 2006-07-31
JP2002521425A (ja) 2002-07-16
NZ509853A (en) 2003-08-29
WO2000006123A1 (en) 2000-02-10
DE69930642T2 (de) 2006-12-28
HK1035862A1 (en) 2001-12-14
EP1100468B1 (en) 2006-03-29
CA2338646A1 (en) 2000-02-10
PT1100468E (pt) 2006-07-31
DE69930642D1 (de) 2006-05-18
JP2010168392A (ja) 2010-08-05
AU763975B2 (en) 2003-08-07

Similar Documents

Publication Publication Date Title
CY1107326T1 (el) Μικροσωματιδια με απορροφητικες επιφανειες, μεθοδοι κατασκευης αυτων και χρησεις αυτων
ES2159523T3 (es) Procedimientos de encapsulado y composiciones de encapsulado reticuladas biocompatibles.
ATE203037T1 (de) Vernetzbare polymere
CY2012032I1 (el) Ενωσεις 1,2-διυδροπυριδινης, διεργασια για την παρασκευη των ιδιων και χρηση εξ αυτων
AU2001291687A1 (en) Polyammonium-polysiloxane compounds, methods for the production and use thereof
ID27600A (id) KOMPOSISI PIROLO (2,3d) PIRIMIDIN DAN PENGGUNAANNYA
WO2000048638A3 (en) Multi-mutant diphtheria toxin vaccines
DE69839444D1 (de) Smad 6 und dessen anwendungen
DE69505713D1 (de) Von perhalogenierten Sultonen abgeleiteten Monomere, sowie aus diesen Monomeren hergestellte Polymere
FR2703053B1 (fr) Oligonucleotides agrafes et semi-agrafes, procede de preparation et applications .
PT615751E (pt) Utilizacao de antagonistas de taquinina no tratamento da emese
GB9816659D0 (en) Composition useful for softening, cleaning, and personal care applications and processes for the preparation thereof
IT1295183B1 (it) Macchina operatrice, e relativo procedimento, per la lavorazione di corpi piani.
ZA982857B (en) Composition useful for fabric softening applications and processes for the preparation thereof.
EP0679678A3 (de) Staubarme pulverförmige hydrophile Polymere.
TR27866A (tr) Alken polimerleri üretmeye mahsus yöntem.
DE60034885D1 (de) Enzymlauge und verfahren zu deren herstellung, enzymzubereitung, proteasezubereitungen und proteaseproduzierendes bakterium
PT929299E (pt) 1,2,3,4-tetra-hidro-2-dibenzofuranaminas e 2-aminociclo-hepta ¬b| benzofuranos substituidos
IT1299948B1 (it) Metodo e dispositivo per la formazione di gruppi di articoli appiattiti.
DK1478659T3 (da) Biologisk aktive peptider
PT1358159E (pt) Tartrato e fosfato de 3,4 diaminopiridina, as suas composições farmacêuticas e as suas utilizações
FR2704569B1 (fr) Pavé de forme polygonale, notamment rectangulaire.
IT1292624B1 (it) Macchina operatrice, e relativo procediemento, per la lavorazione di corpi piani.
WO1997039623A3 (en) Improved production of insecticidal proteins
WO2000073345A3 (en) Antibodies specific for mycobacterial polypeptides and uses thereof